Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Cachet Pharmaceutical Co., Ltd.
002462.SZ
-
CNE100000SN0
Compare
Last update : Sep 18, 2026 at 23:49
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Cachet Pharmaceutical Co., Ltd. (002462.SZ) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
10
KbozYDL
Metrics
Value
Rating
Payout ratio
90
MpBOM
4zP6x
Free cash flow payout ratio
8
9ZOLN
MuKRN
3Y Earnings growth
55
r1f94
UaN0p
Dividend streak
98
Pcs4a
iw6S0
Dividend growth streak
60
1Cyu9
N8gbm
5Y Dividend growth
4
adsRQ
fLrgp
15Y Dividend cut
17
Hnex2
V0e2T
15Y Dividend interruption
98
ngTjH
orEtp
Return on equity
4
U9o07
RJ9qZ
Net debt / EBITDA
75
s5Kdb
Oxr2F
Interest coverage
10
eg8i5
mPf6f
Growth
Last update : Jul 30, 2026
2
p0aZWtc
Metrics
Value
Rating
Revenue growth
21
ZptFU
ezkIG
5Y Revenue growth
13
HIxZJ
OesPi
EBITDA growth
3
ap7r0
Financial Strength
Last update : Jul 30, 2026
3
FaCME3
Metrics
Value
Rating
Interest coverage
15
xoXIe
uh4NT
Quick ratio
63
hzoVQ
DSeRu
Debt / Assets
99
A3Ol7
Profitability
Last update : Jul 30, 2026
1
dIf
Metrics
Value
Rating
Gross margin
26
FbHhl
ssi9r
Operating margin
34
8pSD1
0w2V2
Net margin
19
drajL
u1xbM
Momentum
Last update : Sep 20, 2026
4
eqJVl
ESG
No data available currently
Piotroski F
Last update : Sep 4, 2026
7
Unlock this feature
0
3
6
9
Altman Z
Last update : Sep 4, 2026
4
Unlock this feature
0 and -
1.8
3
4.5 and +
lpOoE
5Y EBITDA growth
78
HIjgr
HZIKn
Operating income growth
100
4etuZ
xbHHv
5Y Operating income growth
97
bYVKZ
RQied
Free cash flow growth
20
865C8
ky3ds
5Y Free cash flow growth
20
dR7hw
8Gdn3
Operating cash flow growth
31
H2pED
nUrHz
5Y Operating cash flow growth
17
ShREy
JDFPS
Capex growth
38
f8Xom
TSDtr
2ZL6d
Debt / Equity
83
5rWyx
RdFby
Net debt / EBITDA
13
8OQ94
YdR5r
Cash / Debt
19
J90AF
Wp7mn
Altman Z Score
85
fnbDW
BHASc
Piotroski F Score
27
yNqFi
LjE1K
Capex coverage ratio
39
ehvRL
I76QC
Free cash flow margin
23
4pQXi
J990W
Return on invested capital
21
aaPSG
wBLZF
Return on equity
97
hZb4L
PTmBB
Return on assets
8
4BoIu
oZIm9
Capex / Revenue
59
YdV4E
WpfjS
Profitable years 5Y
14
upkCa
xD8Jb
Metrics
Value
Rating
SMA 50 vs Price
49
LFzLo
98deO
SMA 200 vs Price
42
asYfQ
vS1Oe
SMA 50 vs SMA 200
70
PQocL
UnQLY
1M Decile rank
30
gifBH
zdAUj
6M Decile rank
40
J6Oic
tZxrj
1Y Decile rank
77
boWU0
CZn0N
